Results 151 to 160 of about 2,541 (204)

Analysis of Characteristics and Prognostic Factors of Full-Frequency Idiopathic Sudden Sensorineural Hearing Loss with Hyperlipidemia. [PDF]

Int J Gen Med
Qin F, Wang M, Qiu J, Guo J.
europepmc   +1 more source

Acute obstetric coagulopathy is associated with excess plasmin generation and proteolysis of fibrinogen and factor V. [PDF]

Blood Adv
Collins PW, Whyte CS, de Lloyd L, Narwal A, Bell SF, Gill N, Collis RE, Jenkins PV, Mutch NJ.   +8 more
europepmc   +1 more source

Hemophagocytic lymphohistiocytosis is associated with deficiency and closed conformation of ADAMTS-13. [PDF]

Res Pract Thromb Haemost
Launois A, Valade S, Mariotte E, Galicier L, Azoulay E, Roose E, Vanhoorelbeke K, Veyradier A, Joly BS.   +8 more
europepmc   +1 more source

Association Between Coagulation Fibrinolysis Markers and Severity in Patients with COVID-19. [PDF]

Clin Appl Thromb Hemost
Iwamoto T, Hatayama Y, Yamashita N, Ichikawa H, Kawamura K.   +4 more
europepmc   +1 more source

Endothelial GATA3 is involved in coagulofibrinolytic homeostasis during endotoxin sepsis. [PDF]

Exp Anim
Hayashi M, Ohmori S, Kawai Y, Moriguchi T.   +3 more
europepmc   +1 more source

Acute Necrotizing Ulcerative Gingivitis: A Case Report. [PDF]

Cureus
Gollapudi M, Mohod S, Pankey N, Gatlewar P.   +3 more
europepmc   +1 more source

Early host-parasite interaction models reveal a key role for fibrinolysis in Fasciola hepatica intestinal migration. [PDF]

Parasit Vectors
Serrat J, López-García M, Torres-Valle M, Molina-Hernández V, Ruiz-Campillo MT, Siles-Lucas M, González-Miguel J.   +6 more
europepmc   +1 more source

Practical applications of plasmin (fibrinolysin)

, 1959
Mathews, Maurice Damon
core  

Plasminogen activation and plasmin activity are not necessary to prevent venous thrombosis/thromboembolism.

Blood
Sang Y, Menegatti M, Brody JA, Wiggins KL, Cooley BC, Kapfer KN, Kangro K, de Laat B, Peyvandi F, Flick MJ, Smith NL, Shapiro AD, Wolberg AS.   +12 more
europepmc   +1 more source

Fibrinolysin Treatment of Thromboembolism

JAMA - Journal of the American Medical Association, 1964
Fibrinolysin (Thrombolysin) has been used in various dosage schedules for thromboembolic disorders, but its clinical value has not been established. In this study, a single large intravenous dose was given at onset of anticoagulant therapy to 170 patients with thrombophlebitis, pulmonary embolism, or acute myocardial infarction.
David A Cooper
exaly   +4 more sources